Day One Biopharmaceuticals Inc

1
NAS:DAWN (USA)  
$ 16.52 +0.73 (+4.62%) 11:08 PM EST
At Loss
P/B:
4.16
Volume:
776.82K
Avg Vol (2M):
658.86K
Volume:
776.82K
At Loss
Avg Vol (2M):
658.86K

Business Description

Day One Biopharmaceuticals Inc
NAICS : 325411 SIC : 2834
ISIN : US23954D1090
Description
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
Name Current Vs Industry Vs History
Cash-To-Debt 897.91
Equity-to-Asset 0.92
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -99.6
3-Year EPS without NRI Growth Rate -117.9
3-Year FCF Growth Rate -79.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 77.14
9-Day RSI 65.91
14-Day RSI 60.5
6-1 Month Momentum % 35.73
12-1 Month Momentum % 31.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.72
Quick Ratio 12.72
Cash Ratio 12.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.1
Shareholder Yield % 0.01

Financials (Next Earnings Date:2024-05-01 Est.)

DAWN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DAWN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Day One Biopharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.38
Beta 0
Volatility % 35.98
14-Day RSI 60.5
14-Day ATR ($) 0.824626
20-Day SMA ($) 15.355
12-1 Month Momentum % 31.59
52-Week Range ($) 9.67 - 17.85
Shares Outstanding (Mil) 87.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Day One Biopharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Day One Biopharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Day One Biopharmaceuticals Inc Frequently Asked Questions

What is Day One Biopharmaceuticals Inc(DAWN)'s stock price today?
The current price of DAWN is $16.52. The 52 week high of DAWN is $17.85 and 52 week low is $9.67.
When is next earnings date of Day One Biopharmaceuticals Inc(DAWN)?
The next earnings date of Day One Biopharmaceuticals Inc(DAWN) is 2024-05-01 Est..
Does Day One Biopharmaceuticals Inc(DAWN) pay dividends? If so, how much?
Day One Biopharmaceuticals Inc(DAWN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1